Chemoinformaics analysis of 2-Methylbutyl 2-methylbutyrate
| Molecular Weight | 172.268 | nRot | 5 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 1 |
| Exact Molecular Weight | 172.146 | nRing | 0 |
| Solubility: LogS | -2.544 | nHRing | 0 |
| Solubility: LogP | 3.475 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 31.6399 |
| nHD | 0 | BPOL | 22.6681 |
| QED | 0.596 |
| Synth | 2.907 |
| Natural Product Likeliness | 0.842 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.009 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.363 |
| MDCK | 0.0000246 |
| BBB | 0.978 |
| PPB | 0.578881 |
| VDSS | 1.11 |
| FU | 0.416259 |
| CYP1A2-inh | 0.823 |
| CYP1A2-sub | 0.475 |
| CYP2c19-inh | 0.295 |
| CYP2c19-sub | 0.846 |
| CYP2c9-inh | 0.233 |
| CYP2c9-sub | 0.175 |
| CYP2d6-inh | 0.026 |
| CYP2d6-sub | 0.219 |
| CYP3a4-inh | 0.085 |
| CYP3a4-sub | 0.347 |
| CL | 10.663 |
| T12 | 0.617 |
| hERG | 0.022 |
| Ames | 0.014 |
| ROA | 0.062 |
| SkinSen | 0.752 |
| Carcinogencity | 0.211 |
| EI | 0.97 |
| Respiratory | 0.698 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.916617 |